PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - McInnes, Iain B.
TI  - Inhibitor of Interleukins 12 and 23 Slows Joint Destruction in Psoriatic Arthritis
DP  - 2013 Feb 01
TA  - MD Conference Express
PG  - 15--16
VI  - 13
IP  - 18
4099  - http://mdc.sagepub.com/content/13/18/15.short
4100  - http://mdc.sagepub.com/content/13/18/15.full
AB  - A prespecified integrated analysis of two Phase 3 clinical trials demonstrates that the monoclonal antibody ustekinumab reduces radiographic progression of joint disease in patients with active psoriatic arthritis. This article presents the integrated analysis of the two Phase 3 Multicenter, Randomised, Double-Blind, Placebo-Controlled Trials of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriasis Arthritis [PSUMMIT I and II; NCT01009086; NCT01077362].